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IMPORTANCE Reflectance confocal microscopy (RCM) studies have been performed to
identify criteria for diagnosis of skin neoplasms. However, RCM-based diagnosis is operator
dependent. Hence, reproducibility of RCM criteria needs to be tested.
OBJECTIVE To test interobserver reproducibility of recognition of previously published RCM
descriptors and accuracy of RCM-based skin cancer diagnosis.
DESIGN, SETTING, AND PARTICIPANTS Observational retrospective web-based study of a set of
RCM images collected at a tertiary academic medical center. Nine dermatologists (6 of whom
had3 years of RCM experience) from 6 countries evaluated an RCM study set from 100
biopsy-proven lesions, including 55melanocytic nevi, 20melanomas, 15 basal cell
carcinomas, 7 solar lentigines or seborrheic keratoses, and 3 actinic keratoses. Between June
15, 2010, and October 21, 2010, participanting dermatologists, blinded to histopathological
diagnosis, evaluated 3 RCMmosaic images per lesion for the presence of predefined RCM
descriptors.
MAIN OUTCOMES ANDMEASURES Themain outcomewas identification of RCMdescriptors
with fair to good interrater agreement (κ statistic,0.3) and independent correlation with
malignant vs benign diagnosis on discriminant analysis. Additional measures included
sensitivity and specificity for diagnosis of malignant vs benign for each evaluator, for majority
diagnosis (rendered by5 of 9 evaluators), and for experienced vs recent RCM users.
RESULTS Eight RCM descriptors showed fair to good reproducibility and were independently
associated with a specific diagnosis. Of these, the presence of pagetoid cells, atypical cells at
the dermal-epidermal junction, and irregular epidermal architecture were associated with
melanoma. Aspecific junctional pattern, basaloid cords, and ulceration were associated with
basal cell carcinomas. Ringed junctional pattern and dermal nests were associated with nevi.
Themean sensitivity for the group of evaluators was 88.9% (range, 82.9%-100%), and the
mean specificity was 79.3% (range, 69.2%-90.8%). Majority diagnosis showed sensitivity of
100% and specificity of 80.0%. Sensitivity was higher for experienced vs recent RCM users
(91.0% vs 84.8%), but specificity was similar (80.0% vs 77.9%).
CONCLUSIONS AND RELEVANCE The study highlights key RCM diagnostic criteria for
melanoma and basal cell carcinoma that are reproducibly recognized among RCM users.
Diagnostic accuracy increases with experience. The higher accuracy of majority diagnosis
suggests that there is intrinsically more diagnostic information in RCM images than is
currently used by individual evaluators.
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I n vivo reflectance confocal microscopy (RCM) is a noveltechnique that allowsnoninvasive examinationof the epi-dermis and papillary dermis at cell-level resolution.1 Re-
flectance confocal microscopy studies2,3 have been per-
formed to identify criteria for diagnosis of melanocytic and
nonmelanocytic skinneoplasms. In addition, algorithmshave
beendeveloped forRCM-baseddiagnosisofmelanomaand for
distinction between melanocytic and nonmelanocytic
neoplasms.4,5 Use ofRCM in research and clinical settings has
shownthatRCMimprovesdiagnosticaccuracyformelanoma6-9
and for basal cell carcinoma (BCC).10-12
Like many other morphology-based methods, both pat-
tern identification and diagnostic decisions made with RCM
are operator dependent and often related to experience.
Because the knowledge base of RCM is still being formed
and because formal training programs have been launched
only recently, heterogeneity in criteria recognition and in
diagnostic accuracy is expected among different RCM
evaluators.
The aim of the present studywas to test interobserver re-
producibility in recognition of previously published RCMde-
scriptors. We also sought to measure accuracy of RCM-based
skin cancer diagnosis amongevaluatorswith various levels of
experience.
Methods
Study Design
This multicenter web-based study involved evaluators with
various levels ofRCMexperience from6countries. Blinded to
histopathological diagnosis, participantswere asked to evalu-
ate a series of RCM images that were uploaded to a desig-
nated web-based platform (http://invivo.confocaltraining
.com). For each image, participantswere asked to complete an
online evaluation form that included pattern description and
diagnostic judgment. The investigationwas conducted in ac-
cord with the Declaration of Helsinki. Ethics committee ap-
proval, at the institutionAziendaOspedaliero-Universitaria di
Modena Policlinico, University ofModena andReggio Emilia,
Modena, Italy, was waived because the study was based on a
deidentified image database.
The series of imageswas derived from 100 diagnostically
equivocal lesions that had been excised for histopathological
diagnosis because theywere clinicallyordermoscopically sus-
picious for melanoma, but a specific clinical and dermo-
scopic diagnosis couldnot be renderedwith certainty. The se-
riesof 100caseswasconsecutivelyandretrospectivelyselected
by an expert dermoscopist (G.P.) blinded to the final histo-
pathological diagnosis. All included lesions had undergone
RCMimagingof acceptablequality.Noadditional selectioncri-
teria were considered in case selection such as the presence
or lack of pigmentation, diameter, elevation, or other clinical
or dermoscopic attributes.
All included RCM images were collected at the Depart-
ment of Dermatology of theUniversity ofModena andReggio
Emilia (Modena, Italy), and all were rendered a histopatho-
logical diagnosis. The final case series included 55 melano-
cytic nevi, 20 melanomas, 15 BCCs, 7 solar lentigines or seb-
orrheic keratoses, and 3 actinic keratoses.
Each case for evaluation had a high-resolution dermo-
scopic image obtained with a dermoscopic lens (Dermlite
Photo; 3Gen) thatwasattached toadigital camera (CanonG15;
Canon Inc).ThreeRCMmosaic images (6 × 6to8 × 8mm)were
acquired with a commercially available instrument (Viva-
scope1500;MAVIGGmbH). Imageswerehorizontaloptical sec-
tions acquired at different anatomic levels, including one im-
age at the granular spinous layers of the epidermis, one image
at thebasal layer of the epidermis anddermal-epidermal junc-
tion (DEJ), and one image at the level of the superficial der-
mis.TheRCMimageacquisitionmethodsand techniqueshave
been described elsewhere.6 No additional clinical informa-
tion (eg, age andmelanomaor lesionhistory)was provided to
evaluators.
Between June 15, 2010, andAugust 24, 2010, participants
were asked to evaluate 10 cases per week for 10 consecutive
weeks.Theywereasked to complete all theevaluationswithin
6months fromstudy initiation.The last reader’sevaluationwas
received on October 21, 2010. Fifteen individuals were in-
vited,9ofwhomagreed toparticipateasevaluators.Theywere
prospectivelycategorizedasexperiencedRCMusers if theyhad
used RCM for at least 3 years in a clinical setting and catego-
rized as recent RCMusers if they had used RCM for less than 3
years. The definitions for each RCM descriptor, the anatomic
level in the skin, and thehistopathological correlates are listed
in the eTable in the Supplement. In addition, an online glos-
sary of representative examples of RCM descriptors is avail-
able (http://www.confocaltraining.com/tutorial/).
Statistical Analysis
For calculation of diagnostic accuracy, sensitivity, and speci-
ficity, diagnosis was dichotomized as malignant for melano-
mas and BCCs and as benign for nevi, solar lentigines or seb-
orrheic keratoses, and actinic keratoses. Diagnostic accuracy
(calculatedassensitivity × prevalence + specificity × 1 − preva-
lence), sensitivity, and specificity were calculated separately
for each evaluator, for the entire group of evaluators, and for
the subgroups (ie, experienced RCM users vs recent RCM us-
ers). Sensitivity and specificity were also calculated based on
diagnoses rendered by themajority of evaluators (ie, consen-
sual diagnosis by≥5of 9 evaluators).We computedκ statistics
tocalculate interrateragreement.Theκstatistics indicatedgood
reproducibility (>0.5), fair reproducibility (0.3-0.5), orpoor re-
producibility (<0.3).WealsoperformedPearsonχ2analysis (ma-
lignant vs benign diagnosis) to test the hypothesis that fre-
quencies in a 2-way table were independent. Moreover,
discriminant analysis (stepwise method) was carried out to
identify the parameters independently correlatedwithmalig-
nant vs benign diagnosis.
Results
Of9evaluators, 6 (A.S., S.G., P.G., E.M.,M.O., andH.S.R.)were
classifiedasexperiencedRCMusers, and3 (R.P.B.,A.A.M., and
I.S.) were classified as recent RCM users. Three evaluators
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(A.A.M.,M.O., andH.S.R.)were fromtheUnitedStates, 4 from
Europe (Spain [S.G.], Switzerland [R.P.B.], and Italy [E.M. and
I.S.]), 1 from Australia (P.G.), and 1 from Israel (A.S.).
RCMFeature Distribution by Diagnosis and Reproducibility
Diagnostic RCM features showing good to fair reproducibility
that reachedstatistical significance (P < .05)are listed inTable1.
The distribution of these reproducible diagnostic RCM fea-
tures by the final histopathological diagnosis is also summa-
rized. Diagnostic features showing poor or nonsignificant re-
producibility are not included.
Discriminant analysis identified6RCMfeatures indepen-
dently associated with malignancy (Table 1). Three of 6 dis-
criminatory RCM features were more frequently observed in
melanoma. Of these melanoma criteria, the presence of pag-
etoid cells and thepresenceof atypical cells at theDEJ showed
good interrater reproducibility, while irregular epidermal ar-
chitecture showed fair interrater reproducibility. In addition,
3of thediscriminatoryRCMfeaturesweremore frequentlyob-
served in BCCs. All 3 BCC criteria (basaloid cord–like struc-
tures,presenceofulceration,andaspecificDEJpattern)showed
good interrater reproducibility.
Discriminant analysis identified 2RCM features indepen-
dently associated with benign neoplasms. Ringed DEJ pat-
tern was seen more frequently in nevi and showed good in-
terrater reproducibility,while thepresenceofdermalnestswas
seenonly slightlymore frequently in nevi than inmelanomas
and showed fair interrater reproducibility.
Diagnostic Accuracy of Evaluators
Diagnosticaccuracy, sensitivity, andspecificityvaluesobtained
by each evaluator are listed in Table 2. Evaluators attained a
meandiagnosticaccuracyof82.7%(range,76.0%-89.0%),with
amean sensitivity of 88.9% (range, 82.9%-100%) and amean
specificityof 79.3%(range,69.2%-90.8%).Oneevaluator from
the subgroup of experienced RCM users had a sensitivity of
100% and a specificity of 72.3%. Considering sensitivity and
specificity valuesby the subgroupsbasedonRCMexperience,
experiencedRCMusers showedhigher sensitivity but similar
specificity comparedwith recentRCMusers (Table 3). Consid-
eringRCMdiagnosis basedon themajority of evaluators (ren-
deredby≥5of 9 evaluators), a sensitivity of 100%anda speci-
ficity of 80.0%were obtained.
Discussion
In theevolutionofRCM,anoperator-dependent,morphology-
based diagnostic technique, formal teaching of standardized
imaging technique and of image evaluation has been lacking,
and personal experience has been gained in parallel by ex-
perts from different academic centers and countries. Indeed,
comparing and integrating the experience of variousRCMus-
ers would constitute an important milestone for the imple-
mentationofRCMinclinicalpractice.For teachingnovicesand
fordisseminatingdiagnostic algorithms,weneed tobetterun-
derstandwhich RCM criteria for diagnosis of skin cancers are
Table 1. Global RCMPatterns and Specific RCM Features Showing Statistically Significant Good to Fair Reproducibility and Their Frequency
According to the Final Histopathological Diagnosis
Variable κ Statistic
Discriminant Analysis
Coefficient
Histopathological Diagnosis, %
Melanomas BCCs AKs SLs/SKs Melanocytic Nevi
Global RCM Patterns
Aspecific DEJ 0.611a 0.501a 53.9 77.8 59.3 38.1 9.3
Ringed DEJ 0.592a −0.485a 26.1 7.4 29.6 54.0 69.5
Meshwork DEJ 0.408 NS 36.1 3.7 11.1 15.9 33.9
Specific RCM Features
Basaloid cord–like structures 0.829a 1.998a 0.6 80.7 7.4 9.5 1.4
Pagetoid cells 0.586a 0.898a 86.1 21.5 7.4 33.3 21.2
Atypical cells 0.542a 0.658a 90.6 40.7 29.6 34.9 27.5
Ulceration 0.504a 0.544a 6.1 32.6 7.4 4.8 0.4
Irregular epidermal
architecture (irregular
honeycomb or cobblestone
pattern)
0.361 0.268 51.7 31.3 11.1 27.0 10.1
Dermal nests 0.313 −0.265 41.1 4.4 0 20.6 45.1
Junctional nests 0.526 NS 53.9 4.4 11.1 19.0 54.5
Irregular vessels 0.381 NS 2.2 21.5 0 12.7 1.2
Nonedged papillae 0.363 NS 91.1 94.1 96.3 54.0 45.5
Disarrayed or nonvisible
papillary contour
0.361 NS 51.7 31.3 11.1 27.0 10.1
Plump bright cells 0.339 NS 70.0 57.0 55.6 69.8 50.5
Collagen bundles 0.330 NS 27.2 66.7 33.3 30.2 19.6
Abbreviations: AKs, actinic keratoses; BCCs, basal cell carcinomas;
DEJ, dermal-epidermal junction; NS, not significant; RCM, reflectance confocal
microscopy; SLs/SKs, solar lentigines or seborrheic keratoses.
a Good interobserver agreement (κ statistics that are statistically significant)
and independently correlated on discriminant analysis with malignant
(melanomas or BCCs) vs benign (AKs, SLs/SKs, or melanocytic nevi) diagnosis.
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reproducibly recognized and which criteria are currently in-
consistently detected. In addition, we need to determine the
current diagnostic performance of RCM users in recognition
of skin cancer. Finally, by considering the combined experi-
ence of different RCMusers, aswell as the performance of the
top experts,we canbetter understand thepresent state of the
art of RCM, namely, the best diagnostic accuracy that can be
obtained with RCM using current criteria.
We found thatRCMcriteria formelanomadiagnosis show-
ing the highest usefulness across RCM users (based on dis-
criminant analysis and acceptable interobserver agreement)
were thepresenceofpagetoidcells (observed in86.1%ofmela-
nomas), the presence of atypical cells at the DEJ (observed in
90.6% of melanomas), and the presence of irregular epider-
mal architecturewithdisruptionof thenormal honeycombor
cobblestone pattern of epidermal keratinocytes (observed in
51.7%ofmelanomas). ConsideringRCMcriteria used in the al-
gorithmspublishedbyPellacani et al4 andbySegura et al,5 the
presence of atypical cells and the presence of pagetoid cells
are relevant criteria formelanoma diagnosis. The criterion of
nonedged papillae at the DEJ (a major criterion in the algo-
rithm by Pellacani et al4) showed fair interobserver agree-
ment but did not reach significance in discriminant analysis.
Nonedgedpapillaedenotedermalpapillae that arenot sharply
demarcated from the surrounding epidermis, which harbors
noncohesive aggregation of refractile cells.13 The ringed pat-
tern, a protective criterion in the algorithmbySegura et al5 for
melanoma diagnosis when present throughout the lesion,
showedgood interobserver agreement andwas seenmore fre-
quently in nevi in our study. Ringedpattern (seen at lowmag-
nification) and edged papillae (the corresponding high-
magnification descriptor) describe the pattern whereby the
dermal papillae are clearly rimmed by rete ridges with indi-
vidually highlighted basal keratinocytes. However, cerebri-
formnests in thedermis (aminor criterion in the algorithmby
Pellacani et al4) did not show significant agreement. We con-
jecture that RCM criteria found in more superficial anatomic
layers may be more readily identified because there is decay
inRCMlaser light intensitywith increasing imagingdepthand
hence decrease in optical resolution. In addition, RCM crite-
ria considered by users asmore relevant for diagnosismay be
more frequently detected because their perceived relevance
may induce the evaluator to more carefully search for these
parameters throughout the image.Moreover, cerebriformnests
represent a specific (but rarely detected) RCM criterion for
melanoma diagnosis, being characteristic of nodular mela-
noma or of the nodular component in a superficial spreading
melanoma. The low frequency (1.3%) of cerebriform nests in
our data set likely accounts for the statistical insignificance of
this RCM criterion in interobserver agreement analyses. The
other positive criterion for melanoma diagnosis in the algo-
rithms by Pellacani et al4 and by Segura et al5 (ie, the pres-
Table 2. Diagnostic Accuracy, Sensitivity, Specificity, and Proportion of Correctly DiagnosedMalignant
Neoplasms by 9 Evaluators Based on the Level of RCMExperiencea
Evaluator
%
Diagnostic
Accuracy Sensitivity Specificity
Diagnosed as Malignant
Proportion of
Melanomas
(n = 20)
Proportion
of BCCs
(n = 15)
Experienced RCM
user
89.0 85.7 90.8 80.0 93.3
Experienced RCM
user
85.0 88.6 83.1 85.0 93.3
Experienced RCM
user
84.0 91.4 80.0 85.0 100
Experienced RCM
user
84.0 88.6 81.5 90.0 86.7
Recent RCM user 84.0 82.9 84.6 80.0 86.7
Experienced RCM
user
82.0 100 72.3 100 100
Recent RCM user 81.0 82.9 80.0 90.0 73.3
Experienced RCM
user
79.4 91.4 73.0 95.0 86.7
Recent RCM user 76.0 88.6 69.2 85.0 93.3
Overall 82.7 88.9 79.3 158/180 (87.8)b 122/135 (90.4)b
Abbreviations: BCCs, basal cell
carcinomas; RCM, reflectance
confocal microscopy.
a Sensitivity and specificity were
calculated based on diagnosed
malignant neoplasms.
bNumber/total number (percentage).
Table 3. Diagnostic Accuracy, Sensitivity, Specificity, and Proportion of Correctly DiagnosedMalignant
Neoplasms by the Subgroups Based on the Level of RCMExperience and byMajority Diagnosis
Evaluators
% Diagnosed as Malignant, No./Total No. (%)
Diagnostic
Accuracy Sensitivity Specificity
Proportion of
Melanomas
Proportion
of BCCs
Experienced RCM
users
83.9 91.0 80.0 107/120 (89.2) 84/90 (93.3)
Recent RCM users 80.3 84.8 77.9 51/60 (85.0) 38/45 (84.4)
Majority diagnosisa 87.0 100 80.0 20/20 (100) 15/15 (100)
Abbreviations: BCCs, basal cell
carcinomas; RCM, reflectance
confocal microscopy.
a Rendered by at least 5 of 9
evaluators.
Research Original Investigation Skin Cancer Diagnosis With Reflectance Confocal Microscopy
1078 JAMADermatology October 2015 Volume 151, Number 10 (Reprinted) jamadermatology.com
Downloaded From:  by a Universidad de Barcelona User  on 01/10/2018
Copyright 2015 American Medical Association. All rights reserved.
ence of nucleated cells in dermis) was not reproducibly rec-
ognized in this study, probably because of the low frequency
of detection of this RCM criterion.
We also established that RCM criteria for BCC diagnosis
showing thehighest usefulness acrossRCMusers (againbased
ondiscriminantanalysisand interobserveragreement)wereba-
saloid cord–like structures representing neoplastic aggregates
ofBCCs, presenceofulceration, andaspecificDEJpattern. The
latter denotes the overall,mosaic view (akin to lowmagnifica-
tion) appearance of a lesion with a flattened DEJ. The corre-
sponding criterion on individual RCM images (akin to higher
magnification) isnonvisiblepapillae,denotingthecompleteab-
senceofobservable interfacebetweendermalpapillaeandepi-
dermal structures in the samehorizontalRCMsection.13 In line
withourstudy,basaloidcord–likestructuresandnonvisiblepa-
pillae were also emphasized as key RCM criteria by Guitera et
al11 in their BCC diagnostic algorithm. However, other impor-
tant criteria in theBCCalgorithmsbyGuitera et al11 andbyNori
et al10 (namely, polarization of nuclei and epidermal shadow)
did not show significant agreement in our study.
Taken together, these findings confirm that there is con-
sistent recognition of several key diagnostic criteria formela-
noma andBCC.However, fewof the published diagnostic cri-
teria for melanoma and BCC were inconsistently recognized:
agreement on their identification should be further tested, or
RCM users could be better trained in their recognition. Fu-
ture research could also aim at simplification of RCM semiol-
ogy by identifying a shorter list of keyRCMdiagnostic criteria
to facilitate the learning and application of RCM technology
by practicing clinicians.
Overall, the different evaluators in our study, including
those with shorter experience with RCM, showed good diag-
nostic performance, with a mean sensitivity of 88.9% and a
mean specificity of 79.3%. These data are in agreement with
previous studies,4-6,10-12,14,15 confirming the ability ofRCMus-
ers to correctly diagnose most skin cancers and a significant
proportion of benign lesions. Despite variability in use and in
reproducibility of single criteria, good diagnostic perfor-
mance has been previously shown in imaging morphology–
based studies.16 Experienced RCM users had higher sensitiv-
ity thanmorenoviceRCMusers (91.0%vs84.8%),while their
specificity was similar (80.0% vs 77.9%). This suggests that
RCM users improve in skin cancer recognition with experi-
ence.Only 1of9evaluatorsachieved100%sensitivity formela-
nomadiagnosis. Evaluators performing a retrospective analy-
sis of cases and lacking responsibility for not missing a
melanoma ina real-lifepatientmaybe inclined towardachiev-
ing higher specificity, sacrificing sensitivity.17 However, sen-
sitivity in the present study may be lower than that in actual
practice because included caseswere all clinically anddermo-
scopically equivocal and because clinical information (which
maybe critically pertinent for diagnosis andmanagement de-
cisions)wasmissing.8,18,19With regard to specificity, thepres-
enceonRCMof irregular epidermal architecture and thepres-
ence of fewatypical cells or sparse pagetoid cellswere criteria
responsible formostbiopsy-provennevimisclassifiedasmela-
noma by RCM evaluators. In the presence of limited clinical
information (eg, long-standing history of lesion stability), the
differentiation between an earlymelanoma and a nevuswith
atypical RCM features may be extremely difficult at times.20
Whenweanalyzedmajority diagnosis (basedon thediag-
nosis of ≥5 of 9 evaluators), 100% sensitivity was observed,
with a considerably high specificity of 80.0%. Given variabil-
ity in recognition of some RCM criteria, it is likely thatmajor-
ity diagnosis is derived from a more balanced weight attrib-
uted to eachdiagnostic feature detectablewithin difficult-to-
diagnose lesions, consequently minimizing the impact of
subjective interpretation.This finding implies that there is suf-
ficient intrinsic morphologic information in the RCM images
to render a correct diagnosis inmost cases.21 In the context of
telemedicineRCMdiagnosiswith limitedaccess to thefull spec-
trum of clinical information that is available during face-to-
faceexamination,evaluationsperformedbymore thanasingle
RCM reader may minimize the diagnostic error and conse-
quent liability.22 In our study, diagnostic accuracy of RCMdi-
agnosis (82.7% overall) was actually lower than that in other
studies based on RCM images alone. This is likely due to the
inclusionof lesions thatweredermoscopically challenging for
diagnosisbydermoscopyexperts. Inaddition,dermoscopy im-
ages are available to evaluators in real-life RCM-based diag-
nosis for bedside or telemedicine diagnosis.
Our study has limitations. The present series is restricted
in the spectrumofdiagnostic entities and lacks squamous cell
carcinomas. While a broader range of diagnoses could better
highlight the usefulness of RCM in skin cancer diagnosis, the
present study focused on RCM imaging of lesions that were
clinically and dermoscopically suspicious for melanoma.
Conclusions
In conclusion, this studyhighlights thekeyRCMdiagnostic cri-
teria for melanoma and BCC that are reproducibly recognized
amongRCMusers.Equally important, thestudyalsodelineates
RCMcriteria thatareconsideredsignificant fordiagnosisbutare
inconsistently identified byRCMusers. Although themeandi-
agnosticperformanceofindividualRCMuserswashigh,ourfind-
ingsalsosuggest that there is intrinsicallymorediagnostic infor-
mationinRCMimagesthaniscurrentlyusedbyindividualevalu-
ators.ThisemphasizestheneedforthecommunityofRCMusers
toengage insharingofRCMcasesandtocontinueto improve in-
terobserver agreement onRCMcriteria.
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